tolvaptan has been researched along with Hepatic Veno Occlusive Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inui, Y; Kakiuchi, S; Kawamori-Iwamoto, Y; Kurata, K; Matsuoka, H; Minami, H; Miyata, Y; Murayama, T; Okamura, A; Sanada, Y; Tomioka, H; Yakushijin, K; Yamamoto, K | 1 |
1 other study(ies) available for tolvaptan and Hepatic Veno Occlusive Disease
Article | Year |
---|---|
Tolvaptan as an alternative treatment for refractory fluid retention associated with sinusoidal obstruction syndrome after allogeneic stem cell transplantation.
Topics: Adult; Benzazepines; Edema; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Male; Tolvaptan; Transplantation, Homologous | 2013 |